Position
Chief Financial Officer
Company
ANAPTYSBIO INC
Description
AnaptysBio, Inc. has announced the appointment of Christopher Murphy as Chief Financial Officer, enhancing its leadership team with his extensive experience in finance and business development. This addition aims to strengthen the company's focus on maximizing shareholder value.
Quick answer
AnaptysBio Appoints Christopher Murphy as Chief Financial Officer (May 11, 2026). ANAPTYSBIO INC is based in San Diego, California, United States.
- Who is the new Chief Financial Officer at ANAPTYSBIO INC?
- ANAPTYSBIO INC named Christopher Murphy Chief Financial Officer, announced May 11, 2026.
- What did ANAPTYSBIO INC announce on May 11, 2026?
- AnaptysBio, Inc. has announced the appointment of Christopher Murphy as Chief Financial Officer, enhancing its leadership team with his extensive experience in finance and business development. This addition aims to strengthen the company's focus on maximizing shareholder value.
- What does ANAPTYSBIO INC do?
- AnaptysBio develops antibody therapeutics based on somatic hypermutation.
- Where is ANAPTYSBIO INC based?
- ANAPTYSBIO INC is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Zura Bio (May 13, 2026), Infinimmune (May 13, 2026), OnCusp Therapeutics (May 14, 2026) and Menarini Group (May 7, 2026) also announced leadership changes within 45 days of ANAPTYSBIO INC.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Zura Bio Appoints Muzammil Mustufa as Chief Business Officer (May 13, 2026)
- Infinimmune Appoints Srikanth Pendyala as Chief Medical Officer (May 13, 2026)
- OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer (May 14, 2026)
- Menarini Group Appoints Thomas Cueni as New Director (May 7, 2026)
- TORL BioTherapeutics Appoints Aran Maree, M.D., as Chief Executive Officer (May 7, 2026)
- Anavex Life Sciences Appoints Dr. Terrie Kellmeyer as Interim Chief Executive Officer (May 6, 2026)
Who to call at ANAPTYSBIO INC, and when
A new leader at ANAPTYSBIO INC brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day ANAPTYSBIO INC raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ANAPTYSBIO INC, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ANAPTYSBIO INC. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ANAPTYSBIO INC changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ANAPTYSBIO INC changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.